Skip to main content

Animations

MJFF Publications

6591 - 6600 of 8785 Results
Title
Year
  • Year
  • 2023
  • 2022
  • 2020
  • 2015
  • 2019
  • 2025
  • 2014
  • 2023
  • 2020
  • 2013
  • Summary Details
    OPEN
    Title: Effects of Parkin on the Mitochondrial Genome in the Heart and Brain of Mitochondrial Mutator Mice
    Journal Name: Advanced Biology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/adbi.202300154
    Citation Count: 2
  • Summary Details
    OPEN
    Title: How Vacations Affect Parkinson's Disease
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13597
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Improving anxiety in Parkinson's disease: A cautionary tale about mobile health technologies
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.03.010
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2015.07.032
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.025
    Citation Count: 21
  • Summary Details
    OPEN
    Title: The role of autophagy in synucleinopathy: clearance versus spread of α-synuclein
    Journal Name: Autophagy Reports
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1080/27694127.2025.2577406
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.007
    Citation Count: 35
  • Summary Details
    OPEN
    Title: GABAA Receptor Benzodiazepine Binding Sites and Motor Impairments in Parkinson’s Disease
    Journal Name: Brain Sciences
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/brainsci13121711
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: From correlational approaches to meta-analytical symptom reading in individual patients: Bilateral lesions in the inferior frontal junction specifically cause dysexecutive syndrome
    Journal Name: Cortex
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.cortex.2020.03.010
    Citation Count: 13
  • Summary Details
    OPEN
    Title: The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.07.013
    Citation Count: 38
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.